Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Retlirafusp Alfa + Bevacizumab + Chemotherapy +/- SCRT in Colorectal Cancer Liver Metastases
NCT07728019Phase 2Recruiting
- Start
- Jul 2026
- Primary completion
- Jun 2029
- Countries
- 1
01
Overview
A Phase 2 trial of retlirafusp alfa in colorectal cancer (CRC). Started Jul 2026; status: recruiting.
02
Drugs
retlirafusp alfa
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT07728019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07728019.